EGFR and neoplasm: Targets for tumor-specific targeting to several tumors are the epidermal growth factor receptor (EGFR), folic acid receptor, lectins, holo-transferrin, hyaluronic acid, cell type-specific peptides encoding the arginine, glycine, and aspartate (RGD) sequence, or antibodies against CD22 or CD30.